[ORGANIZATION]
OneSource Specialty
Featured in 2 tracked stories · first seen
Situations
Brazil plans semaglutide integration into SUS
10 clusters · 125 sources · last updated
Latest: Anvisa approves five new GLP-1 medications for diabetes and obesity
The Brazilian Ministry of Health is progressing with plans to incorporate semaglutide-based weight-loss medications into the Unified Health System (SUS). On September 24, 2026, the Ministry submitted a formal request to
Also covered in
-
Anvisa approves five new diabetes and obesity medication pens in Brazil
[HEALTH] · 10 sources ·